Research
5 min read
Cagrilintide: an amylin analogue in metabolic research
An amylin analogue from a different hormone family, studied alongside other metabolic peptides in research models.
Read article
Cagrilintide
Cagrilintide 5mg
For in vitro research only
A long-acting amylin analogue supplied as a 5 mg lyophilized vial for research into appetite regulation and body-weight control.
Third-party testedView certificate
$150.84
Quantity
1
- Free shipping from $300
- Same-day shipping — order before 1 PM
- Secure payment
Promotion
Free 3 ml bacteriostatic water with every order.
Everything you need to start is included.
New
Advanced lab tests
HPLC tests
Endotoxin assay
TYMC test
TAMC test
Heavy metals screening
Technical specification
- Molecular formula
- C₁₉₄H₃₁₂N₅₄O₅₉S₂·H₄O₂
- Molar mass
- 4409.01 g/mol
- Purity
- ≥99%
- Synonyms
- AM833
- Solubility
- Water-soluble (reconstitute with bacteriostatic water)
- Organoleptic profile
- White to off-white lyophilized powder
- Composition
- Synthetic peptide — requires reconstitution
Key attributes
Kit contents
- 1 × Cagrilintide 5mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
Each vial is intended for laboratory use only.
Research usage
How is Cagrilintide 5mg used in research?
Cagrilintide is a long-acting analogue of amylin, a peptide co-secreted with insulin. In animal research it has been studied for obesity and type 2 diabetes, as well as for liver and cardiovascular endpoints. Much research focuses on combining cagrilintide with semaglutide, where the two appear to act synergistically on appetite regulation and body weight.
In research models the combination of cagrilintide and semaglutide (often referred to as CagriSema) produced more robust and durable weight-loss effects than either agent alone. Preclinical studies suggest promising metabolic potential, though human clinical data remain limited and ongoing.
As an amylin analogue, the most commonly reported research observations are gastrointestinal, including nausea, and are generally dose-dependent. Clinical safety characterization is still emerging and further research is required to define its profile.
Recommended ratio
- 0.5 mL of bacteriostatic water per 5 mg vial
- Equivalent to 10 mg/mL (i.e. 1 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
Research journal